Latest Oxycodone Stories
CANTON, Mass., Feb. 12, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Abuse-Deterrent Drug Formulation" US Patent Application Number 12/823,628. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued....
Does your patient (or family member) need to have controlled access to pain medications? The e-pill Med-O-Wheel SECURE keeps vital meds under lock and key yet properly dosed. Boston, MA (PRWEB) February 06, 2013 For patients undergoing treatment with habit forming medications / scheduled medications / pain pills (such as Oxycodone®, Vicodin®, Dilaudid®, Suboxone®) or antipsychotics, Boston based e-pill Medication Reminders today announced the availability of a locked...
BEVERLY HILLS, Calif., Feb. 4, 2013 /PRNewswire/ -- Following recommendations from an advisory panel to the United States Food and Drug Administration (FDA) proposing tighter restrictions on hydrocodone drugs, for example Vicodin, Norco and Lortab, Clare Waismann, registered addiction specialist and administrative director for the WAISMANN METHOD® opiate treatment, is urging doctors nationwide to practice restraint in prescribing these medications due to their highly-addictive...
redOrbit Staff & Wire Reports - Your Universe Online The number of New York City residents who died as a result of prescription opioid overdose was seven times higher in 2006 than it was just 16 years earlier, according to a new Columbia University study. As part of the study, which is detailed in the latest edition of the journal Drug and Alcohol Dependence, lead author Dr. Magdalena Cerdá, an assistant professor of epidemiology at the university’s Mailman School of Public...
NEW YORK, Jan. 28, 2013 /PRNewswire/ -- Sunday's front page of The New York Times New York edition headlined, "F.D.A. Likely to Add Limits on Painkillers," an advisory panel to the Food and Drug Administration voted 19 to 10 to recommend increased restrictions on hydrocodone products, the country's most widely used narcotic painkillers. Painkillers now take the lives of more Americans than heroin and cocaine combined, and since 2008, drug-induced deaths have outstripped those from...
redOrbit Staff & Wire Reports - Your Universe Online A panel of medical experts is advising the US Food and Drug Administration (FDA) to tighten restrictions on painkillers that contain the substance hydrocodone – a move intended to make it more difficult to prescribe and, ideally, help to curb abuse of the addictive substance. According to Reuters, the panel voted 19-10 in favor of reclassifying all medications containing less than 15 milligrams of hydrocodone, which include...
CANTON, Mass., Jan. 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to Canton, Massachusetts from Cumberland, Rhode Island. The Company's lead development program is Oxycodone DETERx(®) (COL-003), a tamper-resistant, extended-release oxycodone product utilizing its proprietary DETERx(®...
The Wall Street Journal recently reported that doctors who once championed the use of opioid-based prescriptions are reconsidering their evangelism of drugs like OxyContin, Percocet and Vicodin. Physician’s Technology, LLC is on a mission to remove one billion of these addictive and deadly pills from the streets. Monroe, MI (PRWEB) January 03, 2013 In light of recent reporting by the Wall Street Journal, Physician’s Technology, LLC is renewing its pledge to remove one billion harmful...
BEVERLY HILLS, Calif., Jan. 2, 2013 /PRNewswire/ -- An "abuse-proof" formulation of OxyContin may have helped reduce the number of patients abusing the drug, but Dr. Michael Lowenstein, medical director for WAISMANN METHOD® opiate detoxification and treatment, is voicing alarm at recent data showing it may have consequentially resulted in a sharp increase in heroin and other opioid drug use. "After the new abuse-resistant OxyContin was released, I expressed concerns that it could...
ATLANTA, Dec. 20, 2012 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that new patents have been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant SMART/Script(TM) drug delivery platform. U.S. Patent Nos. 8,187,636 and 8,349,362 contain claims that cover Atlantic's proprietary tamper-resistant platform which are designed to resist dose dumping of orally delivered opioids and may sequester and...
